Can Testosterone Cause Myopericarditis?
Timeline
Timestamp
Topic
00:00
A 36-year-old man describes severe myopericarditis after years of using approximately 250 mg of testosterone weekly and asks whether testosterone may have caused the cardiac problem.
02:43
Persistent chest inflammation after five months leads Dr. O’Connor to recommend evaluation by a physician specializing in pericardial disease and to question whether cardiac MRI or other testing is still needed.
07:53
Dr. O’Connor reviews treatment for chronic pericarditis, including colchicine, NSAID therapy, inflammatory markers such as CRP and sedimentation rate, and the importance of monitoring response before increasing treatment.
10:17
The discussion moves to patients who do not respond adequately to first-line therapy, including inflammatory phenotypes and the possible role of anti-IL-1 treatment instead of repeated corticosteroid exposure.
12:50
Dr. O’Connor discusses additional options for refractory chronic pericarditis, including azathioprine, intravenous immunoglobulin, and in severe cases surgical pericardiectomy.
18:32
The member asks about hemoglobin of 18.7 and hematocrit of 54.8 despite being off testosterone for five months, prompting discussion of iron studies, ferritin, hereditary hemochromatosis, and other causes of persistent erythrocytosis.
Video Summary
A 36-year-old man asks whether years of testosterone use caused severe myopericarditis and lingering chest inflammation. Dr. O’Connor reviews his history of approximately 250 mg of testosterone weekly, a sudden episode of severe chest pain, an ejection fraction that fell to 48%, and continued inflammation despite improvement in cardiac function.
The discussion focuses on chronic pericarditis and the need for more specialized evaluation. Dr. O’Connor questions whether the member has received a sufficiently complete workup, discusses cardiac MRI, inflammatory markers, infectious and autoimmune causes, and reviews anti-inflammatory treatment with colchicine, NSAIDs, corticosteroids, and more advanced therapies for refractory disease.
Later, the member asks about low testosterone after stopping long-term therapy and whether restarting a small dose is reasonable. The conversation also shifts to unexpectedly high hemoglobin and hematocrit despite being off testosterone for five months, leading Dr. O’Connor to recommend iron studies and consideration of other causes such as hereditary hemochromatosis rather than assuming testosterone alone explains the abnormal blood counts.
Drug Callouts
Drug
Description
Testosterone
The member had used approximately 250 mg of testosterone weekly for several years before developing myopericarditis and stopped after his cardiologist attributed the condition to testosterone. Dr. O’Connor disputes that explanation in this case and later discusses restarting a much smaller testosterone dose because the member remains symptomatic after long-term suppression.
Colchicine
The member is taking colchicine twice daily for ongoing pericardial inflammation. Dr. O’Connor discusses colchicine as a central part of first-line treatment for recurrent or chronic pericarditis and notes that prolonged therapy may be required depending on recurrence and specialist guidance.
Prednisone
Prednisone was used earlier in the member’s treatment and initially relieved his symptoms before the pain returned. Dr. O’Connor repeatedly cautions against relying on repeated corticosteroid treatment for chronic pericarditis when other anti-inflammatory or specialist-directed options may be appropriate.
Spironolactone
The member is taking spironolactone as part of his cardiac medication regimen. Dr. O’Connor later discusses the drug again when the member wonders whether its diuretic effect could explain his elevated hemoglobin and hematocrit and also notes its potential to cause gynecomastia.
Dapagliflozin (Farxiga)
The member is taking dapagliflozin as part of his current cardiac treatment. Dr. O’Connor identifies it as Farxiga and notes its relationship to Jardiance while reviewing the medications being used after the member’s reduced ejection fraction and inflammatory cardiac illness.
Enalapril
Enalapril is part of the member’s current cardiac regimen following myopericarditis and reduced ejection fraction. It is discussed while Dr. O’Connor reviews the medications being used to support cardiovascular recovery and determine whether the current treatment plan is sufficiently comprehensive.
Condition Callouts
Condition
Description
Myopericarditis
The member was diagnosed with both myocarditis and pericarditis after years of testosterone use and experienced severe chest pain with reduced cardiac function. Dr. O’Connor does not believe the testosterone exposure alone explains the presentation and instead raises infectious or inflammatory causes that require specialist evaluation.
Chronic Pericarditis
Persistent chest inflammation repeatedly returns when the member increases physical activity, leading Dr. O’Connor to describe the problem as chronic pericarditis. For a man with a history of testosterone use, he emphasizes separating the ongoing pericardial disease from assumptions that androgen exposure is automatically the cause.
Cardiomyopathy
The member’s ejection fraction previously fell to approximately 48% and later improved to about 56%, with left ventricular dilation also reportedly resolving. Dr. O’Connor considers a viral cardiomyopathy among the possible explanations rather than assuming long-term testosterone use directly caused the reduced heart function.
Erythrocytosis
The member reports hemoglobin of 18.7 and hematocrit of 54.8 even after five months without testosterone. Because testosterone can raise red blood cell production but the abnormal values have persisted after discontinuation, Dr. O’Connor recommends investigating additional causes rather than attributing the erythrocytosis solely to prior androgen use.
Hereditary Hemochromatosis
Dr. O’Connor raises hereditary hemochromatosis as a possible but unconfirmed explanation for persistent elevated blood counts and potentially cardiac involvement. He recommends iron studies, ferritin, and transferrin saturation because a man previously using testosterone may have more than one factor contributing to abnormal hematologic or cardiac findings.
Coronary Artery Disease
Dr. O’Connor explains that an echocardiogram does not evaluate the inside of the coronary arteries and asks about cholesterol, family history, and possible coronary imaging. In a man with years of testosterone exposure and a cardiac event, he emphasizes evaluating underlying atherosclerotic risk separately from the diagnosis of pericarditis.
Key Takeaways
- Dr. O’Connor does not believe long-term testosterone use alone adequately explains this member’s myopericarditis and persistent pericardial inflammation.
- Persistent or recurrent pericarditis warrants specialist evaluation because infectious, inflammatory, autoimmune, and other causes may require different treatment approaches.
- Colchicine and anti-inflammatory therapy are central to the discussion, while repeated corticosteroid exposure is approached cautiously when symptoms continue to recur.
- More advanced therapies may be considered when chronic pericarditis does not respond adequately to first-line treatment and remains functionally disabling.
- Low testosterone after years of exogenous use may persist after stopping therapy, but restoring testosterone should be considered alongside the member’s unresolved cardiac condition.
- Persistently high hemoglobin and hematocrit after stopping testosterone require further evaluation because prior androgen use may not be the only cause.